Literature DB >> 11814768

Modulatory effect of macrolide antibiotics on the Th1- and Th2-type cytokine production.

K Morikawa1, J Zhang, M Nonaka, S Morikawa.   

Abstract

The effect of the macrolide antibiotics, clarithromycin, midecamycin acetate and josamycin, on the generation of Th1- and Th2-type cytokines by mitogen-stimulated human T lymphocytes was compared with that of fosfomycin. The following results were obtained. These drugs demonstrated potent inhibitory activity on the release and gene expression of TNF-alpha and IL-2. Their inhibitory effect on IFN-alpha, IL-4, IL-5, IL-6 was less marked. The release of IL-10 was poorly suppressed. Clarithromycin had the most potent inhibitory effect of the drugs used. The present results suggested that anti-bacterial agents might modify the host's immunological response by interfering with the activity of T helper cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11814768     DOI: 10.1016/s0924-8579(01)00457-5

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  19 in total

1.  Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases.

Authors:  Itsuro Kazama; Tsutomu Tamada; Masahiro Tachi
Journal:  Inflamm Res       Date:  2015-07-24       Impact factor: 4.575

Review 2.  Physiological significance of delayed rectifier K(+) channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease.

Authors:  Itsuro Kazama
Journal:  J Physiol Sci       Date:  2014-08-06       Impact factor: 2.781

Review 3.  Mechanisms of action and clinical application of macrolides as immunomodulatory medications.

Authors:  Soichiro Kanoh; Bruce K Rubin
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 4.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

5.  Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells.

Authors:  K Sugiyama; R Shirai; H Mukae; H Ishimoto; T Nagata; N Sakamoto; H Ishii; S Nakayama; K Yanagihara; Y Mizuta; S Kohno
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

6.  Immunomodulatory effects of fosfomycin in experimental human endotoxemia.

Authors:  Robert Sauermann; Claudia Marsik; Ilka Steiner; Katja Seir; Tuende Cvitko; Markus Zeitlinger; Oswald Wagner; Christian Joukhadar
Journal:  Antimicrob Agents Chemother       Date:  2007-03-12       Impact factor: 5.191

7.  Topical azithromycin and clarithromycin inhibit acute and chronic skin inflammation in sensitized mice, with apparent selectivity for Th2-mediated processes in delayed-type hypersensitivity.

Authors:  Vanesa Ivetić Tkalčević; Snježana Cužić; Miroslava Dominis Kramarić; Michael J Parnham; Vesna Eraković Haber
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

8.  Effect of Clarithromycin on the Expression of UL16-Binding Protein 2 in Human Cells.

Authors:  Kensaku Okada; Hiroki Chikumi; Miyako Takata; Kosuke Yamaguchi; Haruhiko Makino; Tsuyoshi Kitaura; Masaki Nakamoto; Akira Yamasaki; Tadashi Igishi; Naoto Burioka; Eiji Shimizu
Journal:  Yonago Acta Med       Date:  2015-03-27       Impact factor: 1.641

9.  Cytokine correlations in youth with tic disorders.

Authors:  E Carla Parker-Athill; Jared Ehrhart; Jun Tan; Tanya K Murphy
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-02-06       Impact factor: 2.576

10.  Anti-inflammatory effects of clarithromycin in ventilator-induced lung injury.

Authors:  Laura Amado-Rodríguez; Adrián González-López; Inés López-Alonso; Alina Aguirre; Aurora Astudillo; Estefanía Batalla-Solís; Jorge Blazquez-Prieto; Emilio García-Prieto; Guillermo M Albaiceta
Journal:  Respir Res       Date:  2013-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.